IDH1-Mutated Cholangiocarcinoma: Understanding PARP Inhibitors and Clinical Trials By Steve|2024-10-14T16:43:27+13:00September 25th, 2024|Categories: All, Q&A, Z-Legacy|Tags: ATR Inhibitors, clinical, Clinical Trial, iCCA, IDH1 Mutation, PARP Inhibitors, RAD-3, Shruti| Read More 0
Understanding BRCA1 and BRCA2 in Cholangiocarcinoma By Steve|2024-10-13T19:18:54+13:00August 10th, 2024|Categories: All, Genes, Z-Legacy|Tags: BAP1, BRCA1, BRCA2, Clinical Trial| Read More 0
Exploring the TAS-120-205 Trial: Understanding FGFR2 Inhibitor Impact on Cholangiocarcinoma Treatment” By Steve|2024-10-13T19:18:56+13:00July 31st, 2024|Categories: All, Drug Reviews, Trials & Studies, Z-Legacy|Tags: 120-205, Clinical Trial, FGFR2, TAS, Tiaho| Read More 0
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer By Steve|2024-10-11T16:08:05+13:00December 2nd, 2022|Categories: Publication, Z-Legacy|Tags: Clinical Trial, durvalumab, Topaz| Read More 0